Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 205

1.

The complexities and challenges of preventing and treating nontuberculous mycobacterial diseases.

Baldwin SL, Larsen SE, Ordway D, Cassell G, Coler RN.

PLoS Negl Trop Dis. 2019 Feb 14;13(2):e0007083. doi: 10.1371/journal.pntd.0007083. eCollection 2019 Feb. Review.

2.

Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance.

Manson AL, Cohen KA, Abeel T, Desjardins CA, Armstrong DT, Barry CE 3rd, Brand J; TBResist Global Genome Consortium, Chapman SB, Cho SN, Gabrielian A, Gomez J, Jodals AM, Joloba M, Jureen P, Lee JS, Malinga L, Maiga M, Nordenberg D, Noroc E, Romancenco E, Salazar A, Ssengooba W, Velayati AA, Winglee K, Zalutskaya A, Via LE, Cassell GH, Dorman SE, Ellner J, Farnia P, Galagan JE, Rosenthal A, Crudu V, Homorodean D, Hsueh PR, Narayanan S, Pym AS, Skrahina A, Swaminathan S, Van der Walt M, Alland D, Bishai WR, Cohen T, Hoffner S, Birren BW, Earl AM.

Nat Genet. 2017 Mar;49(3):395-402. doi: 10.1038/ng.3767. Epub 2017 Jan 16.

3.

Investigation of isoniazid and ethionamide cross-resistance by whole genome sequencing and association with poor treatment outcomes of multidrug-resistant tuberculosis patients in South Africa.

Malinga L, Brand J, Jansen van Rensburg C, Cassell G, van der Walt M.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S36-S37. doi: 10.1016/j.ijmyco.2016.11.020. Epub 2016 Nov 25.

4.

Differential recognition of the multiple banded antigen isoforms across Ureaplasma parvum and Ureaplasma urealyticum species by monoclonal antibodies.

Aboklaish AF, Ahmed S, McAllister D, Cassell G, Zheng XT, Spiller OB.

J Microbiol Methods. 2016 Aug;127:13-19. doi: 10.1016/j.mimet.2016.05.015. Epub 2016 May 18.

PMID:
27208664
5.

Draft Genome Sequences of Two Extensively Drug-Resistant Strains of Mycobacterium tuberculosis Belonging to the Euro-American S Lineage.

Malinga LA, Abeel T, Desjardins CA, Dlamini TC, Cassell G, Chapman SB, Birren BW, Earl AM, van der Walt M.

Genome Announc. 2016 Mar 3;4(2). pii: e01771-15. doi: 10.1128/genomeA.01771-15.

6.

Populations of latent Mycobacterium tuberculosis lack a cell wall: Isolation, visualization, and whole-genome characterization.

Velayati AA, Abeel T, Shea T, Konstantinovich Zhavnerko G, Birren B, Cassell GH, Earl AM, Hoffner S, Farnia P.

Int J Mycobacteriol. 2016 Mar;5(1):66-73. doi: 10.1016/j.ijmyco.2015.12.001. Epub 2015 Dec 28.

7.

Community-based care vs. centralised hospitalisation for MDR-TB patients, KwaZulu-Natal, South Africa.

Loveday M, Wallengren K, Brust J, Roberts J, Voce A, Margot B, Ngozo J, Master I, Cassell G, Padayatchi N.

Int J Tuberc Lung Dis. 2015 Feb;19(2):163-71. doi: 10.5588/ijtld.14.0369.

8.

Shifting gears to control drug-resistant tuberculosis.

Berkelman RL, Cassell GH, Whitney EA, Keshavjee S.

Clin Infect Dis. 2014 Sep 15;59(6):908-10. doi: 10.1093/cid/ciu479. Epub 2014 Jun 18. No abstract available.

PMID:
24944229
9.

Inflammation and tuberculosis: host-directed therapies.

Zumla A, Rao M, Parida SK, Keshavjee S, Cassell G, Wallis R, Axelsson-Robertsson R, Doherty M, Andersson J, Maeurer M.

J Intern Med. 2015 Apr;277(4):373-87. doi: 10.1111/joim.12256. Epub 2014 May 19. Review.

10.

Comparative genome analysis of 19 Ureaplasma urealyticum and Ureaplasma parvum strains.

Paralanov V, Lu J, Duffy LB, Crabb DM, Shrivastava S, Methé BA, Inman J, Yooseph S, Xiao L, Cassell GH, Waites KB, Glass JI.

BMC Microbiol. 2012 May 30;12:88. doi: 10.1186/1471-2180-12-88.

11.

Outcomes of multi-drug resistant tuberculosis (MDR-TB) among a cohort of South African patients with high HIV prevalence.

Farley JE, Ram M, Pan W, Waldman S, Cassell GH, Chaisson RE, Weyer K, Lancaster J, Van der Walt M.

PLoS One. 2011;6(7):e20436. doi: 10.1371/journal.pone.0020436. Epub 2011 Jul 22.

12.

Extensive horizontal gene transfer in ureaplasmas from humans questions the utility of serotyping for diagnostic purposes.

Xiao L, Paralanov V, Glass JI, Duffy LB, Robertson JA, Cassell GH, Chen Y, Waites KB.

J Clin Microbiol. 2011 Aug;49(8):2818-26. doi: 10.1128/JCM.00637-11. Epub 2011 Jun 22.

13.

Detection and characterization of human Ureaplasma species and serovars by real-time PCR.

Xiao L, Glass JI, Paralanov V, Yooseph S, Cassell GH, Duffy LB, Waites KB.

J Clin Microbiol. 2010 Aug;48(8):2715-23. doi: 10.1128/JCM.01877-09. Epub 2010 Jun 16.

14.

Deficient immune response to Mycoplasma pneumoniae in childhood asthma.

Atkinson TP, Duffy LB, Pendley D, Dai Y, Cassell GH.

Allergy Asthma Proc. 2009 Mar-Apr;30(2):158-65. doi: 10.2500/aap.2009.30.3207.

PMID:
19463205
15.

Ureaplasma parvum or Mycoplasma hominis as sole pathogens cause chorioamnionitis, preterm delivery, and fetal pneumonia in rhesus macaques.

Novy MJ, Duffy L, Axthelm MK, Sadowsky DW, Witkin SS, Gravett MG, Cassell GH, Waites KB.

Reprod Sci. 2009 Jan;16(1):56-70. doi: 10.1177/1933719108325508. Epub 2009 Jan 2.

PMID:
19122105
16.

Grand challenges for psychiatric drug discovery: a perspective.

Brady LS, Giffin RB, Woodcock J, Cassell GH, Holmes EW.

Neuropsychopharmacology. 2008 Aug;33(9):2047. doi: 10.1038/npp.2008.54. No abstract available.

17.

Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever.

Hensley LE, Stevens EL, Yan SB, Geisbert JB, Macias WL, Larsen T, Daddario-DiCaprio KM, Cassell GH, Jahrling PB, Geisbert TW.

J Infect Dis. 2007 Nov 15;196 Suppl 2:S390-9.

PMID:
17940975
18.

The Mre11/Rad50/Nbs1 complex limits adeno-associated virus transduction and replication.

Schwartz RA, Palacios JA, Cassell GD, Adam S, Giacca M, Weitzman MD.

J Virol. 2007 Dec;81(23):12936-45. Epub 2007 Sep 26.

19.
20.

Spermidine biases the resolution of Holliday junctions by phage lambda integrase.

Boldt JL, Kepple KV, Cassell GD, Segall AM.

Nucleic Acids Res. 2007;35(3):716-27. Epub 2006 Dec 19.

21.

The "Achilles heel" of global efforts to combat infectious diseases.

Berkelman R, Cassell G, Specter S, Hamburg M, Klugman K.

Clin Infect Dis. 2006 May 15;42(10):1503-4. No abstract available.

PMID:
16619171
22.

A role for the Mycoplasma pneumoniae adhesin P1 in interleukin (IL)-4 synthesis and release from rodent mast cells.

Hoek KL, Duffy LB, Cassell GH, Dai Y, Atkinson TP.

Microb Pathog. 2005 Oct;39(4):149-58.

PMID:
16169702
23.

Public health workforce development.

Imtiaz R, Cassell G.

Emerg Infect Dis. 2004 Nov;10(11):2051-2. No abstract available.

24.

Generation and characterization of endonuclease G null mice.

Irvine RA, Adachi N, Shibata DK, Cassell GD, Yu K, Karanjawala ZE, Hsieh CL, Lieber MR.

Mol Cell Biol. 2005 Jan;25(1):294-302.

25.
26.

The Rep protein of adeno-associated virus type 2 interacts with single-stranded DNA-binding proteins that enhance viral replication.

Stracker TH, Cassell GD, Ward P, Loo YM, van Breukelen B, Carrington-Lawrence SD, Hamatake RK, van der Vliet PC, Weller SK, Melendy T, Weitzman MD.

J Virol. 2004 Jan;78(1):441-53.

27.

Effects of antenatal colonization with ureaplasma urealyticum on pulmonary disease in the immature baboon.

Yoder BA, Coalson JJ, Winter VT, Siler-Khodr T, Duffy LB, Cassell GH.

Pediatr Res. 2003 Dec;54(6):797-807. Epub 2003 Aug 20.

PMID:
12930907
29.

Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin.

Kraft M, Cassell GH, Pak J, Martin RJ.

Chest. 2002 Jun;121(6):1782-8.

PMID:
12065339
30.

Lung pathology in premature infants with Ureaplasma urealyticum infection.

Viscardi RM, Manimtim WM, Sun CC, Duffy L, Cassell GH.

Pediatr Dev Pathol. 2002 Mar-Apr;5(2):141-50.

PMID:
11910508
31.

Mycoplasma pneumoniae-induced activation and cytokine production in rodent mast cells.

Hoek KL, Cassell GH, Duffy LB, Atkinson TP.

J Allergy Clin Immunol. 2002 Mar;109(3):470-6.

PMID:
11897994
32.

Mycoplasma pneumoniae induces chronic respiratory infection, airway hyperreactivity, and pulmonary inflammation: a murine model of infection-associated chronic reactive airway disease.

Hardy RD, Jafri HS, Olsen K, Hatfield J, Iglehart J, Rogers BB, Patel P, Cassell G, McCracken GH, Ramilo O.

Infect Immun. 2002 Feb;70(2):649-54.

33.

Midtrimester vaginal Mycoplasma genitalium in women with subsequent spontaneous preterm birth.

Lu GC, Schwebke JR, Duffy LB, Cassell GH, Hauth JC, Andrews WW, Goldenberg RL.

Am J Obstet Gynecol. 2001 Jul;185(1):163-5.

PMID:
11483922
34.

Elevated cytokine and chemokine levels and prolonged pulmonary airflow resistance in a murine Mycoplasma pneumoniae pneumonia model: a microbiologic, histologic, immunologic, and respiratory plethysmographic profile.

Hardy RD, Jafri HS, Olsen K, Wordemann M, Hatfield J, Rogers BB, Patel P, Duffy L, Cassell G, McCracken GH, Ramilo O.

Infect Immun. 2001 Jun;69(6):3869-76.

35.

A link between chronic asthma and chronic infection.

Martin RJ, Kraft M, Chu HW, Berns EA, Cassell GH.

J Allergy Clin Immunol. 2001 Apr;107(4):595-601.

PMID:
11295645
37.

The complete sequence of the mucosal pathogen Ureaplasma urealyticum.

Glass JI, Lefkowitz EJ, Glass JS, Heiner CR, Chen EY, Cassell GH.

Nature. 2000 Oct 12;407(6805):757-62.

PMID:
11048724
38.

Peptide inhibitors of DNA cleavage by tyrosine recombinases and topoisomerases.

Klemm M, Cheng C, Cassell G, Shuman S, Segall AM.

J Mol Biol. 2000 Jun 23;299(5):1203-16.

PMID:
10873446
39.

Dissection of bacteriophage lambda site-specific recombination using synthetic peptide combinatorial libraries.

Cassell G, Klemm M, Pinilla C, Segall A.

J Mol Biol. 2000 Jun 23;299(5):1193-202.

PMID:
10873445
40.

Antibody responses after Sendai virus infection and their role in upper and lower respiratory tract disease in rats.

Liang SC, Simecka JW, Lindsey JR, Cassell GH, Davis JK.

Lab Anim Sci. 1999 Aug;49(4):385-94.

PMID:
10480643
41.

Mycoplasma penetrans bacteremia and primary antiphospholipid syndrome.

Yáñez A, Cedillo L, Neyrolles O, Alonso E, Prévost MC, Rojas J, Watson HL, Blanchard A, Cassell GH.

Emerg Infect Dis. 1999 Jan-Feb;5(1):164-7.

42.

The geometry of a synaptic intermediate in a pathway of bacteriophage lambda site-specific recombination.

Cassell G, Moision R, Rabani E, Segall A.

Nucleic Acids Res. 1999 Feb 15;27(4):1145-51.

43.

Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children.

Harris JA, Kolokathis A, Campbell M, Cassell GH, Hammerschlag MR.

Pediatr Infect Dis J. 1998 Oct;17(10):865-71.

PMID:
9802626
44.
45.

Mycoplasma pneumoniae pneumonia in a mouse model.

Wubbel L, Jafri HS, Olsen K, Shelton S, Barton Rogers B, Gambill G, Patel P, Keyser E, Cassell G, McCracken GH.

J Infect Dis. 1998 Nov;178(5):1526-9.

PMID:
9780280
46.

Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma.

Kraft M, Cassell GH, Henson JE, Watson H, Williamson J, Marmion BP, Gaydos CA, Martin RJ.

Am J Respir Crit Care Med. 1998 Sep;158(3):998-1001. Erratum in: Am J Respir Crit Care Med 1998 Nov;158(5 Pt 1):1692.

PMID:
9731038
47.

Infectious causes of chronic inflammatory diseases and cancer.

Cassell GH.

Emerg Infect Dis. 1998 Jul-Sep;4(3):475-87.

48.

Roles of innate and adaptive immunity in respiratory mycoplasmosis.

Cartner SC, Lindsey JR, Gibbs-Erwin J, Cassell GH, Simecka JW.

Infect Immun. 1998 Aug;66(8):3485-91.

49.

Weekly oral azithromycin as prophylaxis for agents causing acute respiratory disease.

Gray GC, McPhate DC, Leinonen M, Cassell GH, Deperalta EP, Putnam SD, Karcher JA, Sawyer MH, Laurila A, Connor JD.

Clin Infect Dis. 1998 Jan;26(1):103-10.

PMID:
9455517
50.

Mycoplasma pulmonis inhibits electrogenic ion transport across murine tracheal epithelial cell monolayers.

Lambert LC, Trummell HQ, Singh A, Cassell GH, Bridges RJ.

Infect Immun. 1998 Jan;66(1):272-9.

Supplemental Content

Loading ...
Support Center